Mirror Now
@mirrornow·2.2M subscribers·145K videos
India have 2 COVID-19 vaccines for roll out, final nod from DCGI awaited
Posted
January 2, 2021
Views
143
Likes
4
Comments
3
Engagement
4.90%
January 2, 2021
143
4
3
4.90%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
22:42Now PlayingAfter Covishield vaccine, the Subject Expert Committee (SEC) has given approval to Bharat Biotech's Covaxin. However, a final nod from the Drugs Controller General of India is yet to come.
After the approval of Bharat Biotech’s Covaxin, India will have two Coronavirus vaccine for the rollout.
But what could be major challenges that we can face as we get to the mass inoculation?
Dr Anant Bhan, Global Health, Bioethics & Health Policy and Dr Rahul Pandit, Member of Maharashtra's Covid-19 Taskforce speak exclusively to Mirror Now’s Avni raja and explain the stages and difficulties that India might face ahead of the COVID-19 vaccine roll out.
SUBSCRIBE NOW for more such videos ►
For More Updates ►
Like us on Facebook ►
Follow us on Twitter ►
Follow us on Instagram ►
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
